The United States cosmetic market is one of the most highly regulated and competitive industries in the world. Any company planning to manufacture, distribute, import, or sell cosmetic products in the United States must comply with strict US FDA cosmetic regulations. Failure to meet these requirements can lead to warning letters, product seizures, import alerts, product recalls, and severe damage to brand reputation.
With the enactment of the Modernization of Cosmetics Regulation Act (MoCRA), cosmetic regulation in the United States has undergone the most significant update in decades. Today, cosmetic companies must meet new obligations related to facility registration, product listing, safety substantiation, labeling, adverse event reporting, and good manufacturing practices (GMP).
XPRO America is a trusted US FDA Consultancy providing professional cosmetic regulatory compliance services to global brands, private label manufacturers, startups, and multinational companies. This article explains everything you need to know about US FDA cosmetic regulations and how to achieve full compliance efficiently.
Understanding What the US FDA Regulates in Cosmetics
In the United States, cosmetics are regulated under the Federal Food, Drug, and Cosmetic Act (FD&C Act). A cosmetic is defined as any product intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance. Examples include:
- Skin care products
- Hair care products
- Makeup and color cosmetics
- Fragrances and perfumes
- Nail care products
- Personal hygiene products
Unlike drugs, cosmetics do not require FDA premarket approval. However, they must be safe for consumer use, properly labeled, and manufactured under sanitary conditions. Companies are legally responsible for ensuring their cosmetic products meet all applicable FDA requirements.
Key Objectives of US FDA Cosmetic Regulations
US FDA cosmetic regulations aim to:
- Protect consumers from unsafe or harmful cosmetic products
- Ensure accurate and truthful labeling
- Prevent adulteration and misbranding
- Improve transparency in cosmetic manufacturing and supply chains
- Enable FDA oversight through facility registration and product listing
With MoCRA now in effect, the FDA has greater authority to inspect facilities, mandate recalls, and enforce compliance.
Facility Registration Under MoCRA
Cosmetic manufacturers and processors must register their facilities with the FDA. This applies to both domestic and foreign facilities that manufacture or process cosmetic products distributed in the United States.
Key points:
- Initial registration required
- Renewal every two years
- Updates required for changes in ownership, address, or activities
- Foreign facilities must designate a US Agent
XPRO America, as a US FDA Consultancy, manages complete facility registration and US Agent services to ensure smooth compliance for international companies.
Cosmetic Product Listing Requirements
Each cosmetic product marketed in the US must be listed with the FDA. Product listing includes submission of:
- Product name and category
- Ingredients list
- Manufacturer or distributor information
- Facility registration number
Product listing must be updated annually and whenever formulation changes occur.
Accurate product listing demonstrates regulatory transparency and reduces compliance risk during FDA inspections or import screening.
Cosmetic Ingredient Compliance
The FDA prohibits or restricts certain cosmetic ingredients. Companies must ensure formulations do not contain banned substances and that restricted ingredients meet usage limits.
Important considerations:
- Prohibited ingredient list
- Restricted ingredient conditions
- Color additive approval status
- Compliance with fragrance allergen labeling (where applicable)
Although the FDA does not pre-approve cosmetic ingredients (except color additives), manufacturers must substantiate product safety.
XPRO America reviews ingredient formulations against FDA regulations and international safety standards to ensure compliance before market entry.
Safety Substantiation Requirement
MoCRA requires companies to maintain adequate safety substantiation for each cosmetic product. This means having scientifically valid evidence demonstrating that a product is safe for its intended use.
Safety substantiation may include:
- Toxicological risk assessments
- Ingredient safety profiles
- Clinical or dermatological testing
- Literature reviews
Failure to maintain safety documentation can result in regulatory enforcement.
XPRO America prepares and organizes safety substantiation dossiers that meet FDA expectations.
Good Manufacturing Practices (GMP) for Cosmetics
Cosmetic products must be manufactured under sanitary and controlled conditions to prevent contamination and quality defects.
Key GMP principles include:
- Hygienic facility design
- Controlled production processes
- Equipment cleaning and maintenance
- Raw material control
- In-process and finished product testing
- Employee training
- Documented procedures
The FDA can inspect cosmetic facilities for GMP compliance. Deficiencies may result in warning letters or import detention.
XPRO America assists companies in implementing cosmetic GMP systems aligned with FDA expectations.
Cosmetic Labeling Requirements
Cosmetic labeling is one of the most critical aspects of FDA compliance. Labels must be truthful, not misleading, and contain specific mandatory elements.
Required labeling elements:
- Product identity
- Net quantity of contents
- Ingredient declaration (INCI names in descending order)
- Manufacturer, packer, or distributor name and address
- Warning statements (if applicable)
Claims must not imply drug-like effects unless the product is regulated as a drug. For example, claims such as “treats acne” or “heals eczema” may trigger drug classification.
XPRO America reviews cosmetic labels to ensure regulatory compliance and minimize enforcement risk.
Adverse Event Reporting
Under MoCRA, companies must report serious adverse events associated with cosmetic products to the FDA within 15 business days.
Serious adverse events include:
- Hospitalization
- Life-threatening reactions
- Significant disability
- Birth defects
- Death
Companies must also maintain records of adverse events for six years.
XPRO America establishes adverse event reporting systems and procedures for cosmetic brands.
Importing Cosmetics into the United States
Foreign cosmetic manufacturers must comply with all FDA regulations prior to importing products into the US.
Key import compliance factors:
- Facility registration
- Product listing
- Accurate customs documentation
- Proper labeling
- Ingredient compliance
Non-compliant shipments may be refused entry or placed on import alert.
XPRO America supports end-to-end import compliance to ensure smooth customs clearance.
FDA Enforcement Actions for Non-Compliance
The FDA has authority to take enforcement actions such as:
- Warning letters
- Product recalls
- Seizure
- Import alerts
- Injunctions
Non-compliance can lead to financial loss and long-term damage to brand reputation.
Working with a professional US FDA Consultancy significantly reduces regulatory risk.
Benefits of Working with XPRO America – US FDA Consultancy
XPRO America provides comprehensive cosmetic regulatory services, including:
- Facility Registration
- Cosmetic Product Listing
- US Agent Services
- Ingredient Compliance Review
- Safety Substantiation
- GMP Consulting
- Labeling Review
- Adverse Event Reporting Systems
- Import Compliance Support
With a global client base and deep regulatory expertise, XPRO America simplifies the complex US FDA compliance process for cosmetic companies.
For professional assistance, you may reach XPRO America’s regulatory team at support@xproamerica.com.
Why Cosmetic Compliance Is a Business Advantage
Beyond avoiding penalties, FDA compliance builds:
- Consumer trust
- Retailer acceptance
- Distributor confidence
- Market expansion opportunities
- Long-term brand sustainability
Compliance is not just a legal obligation—it is a strategic business investment.
Final Thoughts
US FDA cosmetic regulations are evolving, and MoCRA has raised the bar for compliance. Cosmetic companies must take a proactive approach to regulatory compliance to remain competitive in the US market.
Partnering with an experienced US FDA Consultancy like XPRO America ensures your cosmetic products meet all regulatory expectations while allowing you to focus on product innovation and business growth.
For expert US FDA cosmetic compliance services, contact XPRO America today at support@xproamerica.com.
Leave a Reply